Capital Flow Monitor · Sponsors · CIK 2107711
BH3 Heritage FV III Feeder L.P.
819 NE 2ND AVENUE, SUITE 500, FORT LAUDERDALE, FL, 33304 · (954) 416-3140
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
$50.0M
Sold
$15.0M
% sold
30.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-27 | D ·current | 506(b) | $50.0M | $15.0M | 30.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- . BH3 Heritage FV III GP LLC — Director, Fort Lauderdale, FL
-
Daniel Lebensohn — Director, Fort Lauderdale, FL
4 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
-
Gregory Freedman — Director, Fort Lauderdale, FL
4 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
-
. BH3 Fund Advisors, LLC — Director, Fort Lauderdale, FL
4 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
-
Eric Edidin — Executive Officer, Fort Lauderdale, FL
10 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- Illuminare Biotechnologies Inc $3.7M of $4.0M · 91.3%
- ILIAD BIOTECHNOLOGIES, INC. $115.5M of $115.5M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
- Endo Ventures Cecelia SPV, LLC $94K of $94K · 100.0%
- Endo IV Cecelia SPV, LLC $591K of $591K · 100.0%
- Endo G100 Cecelia SPV LLC $109K of $109K · 100.0%
- Cecelia Health Holdings, Inc. $16.1M of $19.1M · 84.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.